Connection

Nadia Aspromonte to Thromboembolism

This is a "connection" page, showing publications Nadia Aspromonte has written about Thromboembolism.
Connection Strength

0.081
  1. Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure. Expert Opin Drug Metab Toxicol. 2017 Jan; 13(1):113-122.
    View in: PubMed
    Score: 0.065
  2. Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials. Monaldi Arch Chest Dis. 2017 05 18; 87(1):805.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.